• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar

CHEM Trust

Protecting humans and wildlife from harmful chemicals

  • Home
    • Our policy site
    • Advice for consumers
  • About us
    • About CHEM Trust
    • CHEM Trust Europe
    • Our team
    • Trustees of CT UK
    • Our funders
    • Contact
    • Jobs
    • Privacy Policy
  • Our work
    • Our work – UK, EU and global
    • Newsletters
    • Publications
    • Talks & comment
    • EU policy submissions
    • UK policy submissions
  • Problem chemicals
    • Hormone Disrupting Chemicals FAQ
    • Bisphenols
    • Phthalates
    • PFAS
    • Pharmaceutical pollution
    • Chemicals and plastics
  • Chemical impacts
    • Health impacts
    • Wildlife impacts
  • Chemicals policy
    • EU-REACH
    • UK policy
    • Chemicals and the Circular Economy
    • Food contact materials
    • Persistent Organic Pollutants (POPs)
    • Chemical mixtures
    • Toxic-free toys
    • Universal PFAS Restriction
  • Take Action

Are the effects of EDCs seen in the laboratory reversible?

Some people have argued that adaptation mechanisms (homeostasis) prevent the occurrence of permanently damaging effects and that the human body should be able to deal with exposure to weak EDCs.

However, they overlook the fact that during development in-utero, one of the periods most sensitive to endocrine disruption, the homeostatic control mechanisms that can operate in the adult are not yet fully formed and are far from being fully functional.

During foetal development detoxification mechanisms and endocrine feed-back loops are immature or absent as has been discussed in the context of the Commission’s JRC Expert Advisory Group on EDCs [i]. When exposure occurs during this “programming window” in early life it can cause irreversible harm. These effects are permanent and sometimes only become apparent in later life [ii]. This sensitivity applies to humans and animals (though sometimes differing between humans and animals depending on the animal and chemical in question).

This page is part of CHEM Trust’s Hormone Disrupting Chemicals FAQ – Full list of questions here.

The next question is “What effects are adverse?“.

 

[i]. JRC report: Thresholds for Endocrine Disrupters and related Uncertainties, Report of the ED expert Advisory Group, published August 2014

[ii]. Barouki et al.: Developmental origins of non-communicable disease: Implications for research and public health, Environmental Health 2012, 11:42. http://www.ehjournal.net/content/11/1/42

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Email a link to a friend (Opens in new window) Email

Primary Sidebar

Sign up to the CHEM Trust Newsletter

CHEM Trust Privacy Notice

Read our latest newsletter

Follow us

  • Bluesky
  • Instagram
  • LinkedIn

Bluesky

Copyright CHEM Trust · Reg Charity No. 1118182 · Disclaimer · Login

Want to keep up-to-date with our work?

Subscribe to the CHEM Trust newsletter.

Subscribe here